The role of resistin in Behçet's disease: A Turkish experiment

Modern Rheumatology

Volumn 22, Issue 4, 2012, Pages 571-575

  Pehlivan, Yavuz ^a   Onat, Ahmet Mesut ^a   Okumuş, Seydi ^a   Kisacik, Bunyamin ^a   Comez, Gazi ^a   Comez, Aysegul ^a   Goktepe, Fatih ^a   Ceylan, Nurdan Ozlu ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Adipokine; Beh et's disease; Inflammation; Resistin; TNF

Indexed keywords

C REACTIVE PROTEIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ADULT; BEHCET SYNDROME; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865356671     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0546-0     Document Type: Review

References (21)

1. Babacan T, Onat AM, Pehlivan Y, Comez G, Tutar E. A case of the Behçet's disease diagnosed by the panniculits after mesotherapy. Rheumatol Int. 2010;30:1657-9.
2. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002. (Pubitemid 32990034)
3. Beutler B, Cerami A. The biology of cachectin/TNF-A primary mediator of the host response. Annu Rev Immunol. 1989;7:625-55. (Pubitemid 19138027)
4. Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, et al. Distribution of four polymorphisms in the tumor necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1996;103:391-6. (Pubitemid 26089943)
5. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993;36:1681-90. (Pubitemid 23360007)
6. Sayinalp N, Oezcebe OI, Oezdemir O, Haznedaroglu CH, Dundar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol. 1996;23:321-2.
7. Mege JL, Dilsen N, Sanguedolace V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544-9. (Pubitemid 24027329)
8. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch Jr. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309:286-90. (Pubitemid 37025889)
9. Filková M, Haluzík M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157-70.
10. Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66:458-63. (Pubitemid 46580464)
11. Yalçindag FN, Yalçindag A, Batioglu F, Caglayan O, Kisa U, Ozdemir O. Evaluation of serum resistin levels in patients with ocular and non-ocular Behçet's disease. Can J Ophthalmol. 2008;43:473-5.
12. Kim SK, Choe JY, Park SH, Lee SW, Lee GH, Chung WT. Increased insulin resistance and serum resistin in Korean patients with Behçet's disease. Arch Med Res. 2010;41:269-74.
13. International Study Group for Behçet's Disease (ISGBD). Criteria for diagnosis of Behet's disease. Lancet. 1990;335:1078-80.
14. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789-95. (Pubitemid 40593223)
15. Stejskal D, Adamovska S, Bartek J, Jurakova R, Proskova J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:63-9.
16. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis inhumans. Circulation. 2005;111:932-9. (Pubitemid 40279897)
17. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596-604. (Pubitemid 43164455)
18. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond). 2005;29: 1315-20. (Pubitemid 41679262)
19. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation tometabolic factors, inflammatory markers, and vascular reactivityin diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004;27:2450-7. (Pubitemid 39281400)
20. Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin isassociated with c-reactive protein & LDL cholesterol in type 2diabetes and coronary artery disease in a Saudi population.Cardiovasc Diabetol. 2005;4:10.
21. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008;26:311-6. (Pubitemid 351659139)